Recherche Peau
Peptides de cuivre et composés pour la recherche dermique. Ci-dessous se trouve la littérature publiée pour chaque composé dans ce domaine — 123 études au total, 62 d'entre elles publiées depuis 2023, chacune liée à son dossier source.
- PeauPréclinique uniquement
AHK-Cu
AHK-Cu (L-alanyl-L-histidyl-L-lysine copper(II), proche de l'INCI de l'ingrédient cosmétique Tripeptide-3) est un analogue structural de GHK-Cu dans lequel la glycine est remplacée par l'alanine. La base de preuves directement publiée est très restreinte : une seule étude ex vivo et en culture cellulaire sur follicules pileux humains et cellules papillaires dermiques constitue la source dermatologique principale, complétée par une étude de délivrance topique de Tripeptide-3 pour le sébum facial et par des travaux sur un dérivé AHK conjugué à la vitamine C dans un modèle non cutané. La plupart des allégations faites pour AHK-Cu sont extrapolées à partir de la littérature plus large sur les tripeptides de cuivre plutôt qu'à partir de données spécifiques à AHK.
- Études
- 10
- Depuis 2023
- 6
- Le plus récent
- 2026
- PeauClinique précoce
GHK-Cu
GHK (glycyl-L-histidyl-L-lysine) is an endogenous human plasma tripeptide that binds copper(II) with high affinity. In cell culture it increases fibroblast collagen and glycosaminoglycan synthesis at picomolar to nanomolar concentrations, and gene-expression work reports broad modulation of extracellular-matrix, antioxidant and inflammatory programmes. Human data are limited: most published work is in vitro or in animal models, and the small number of controlled human trials of topical GHK-Cu have produced mixed results, including two randomised trials that found no advantage over comparator or placebo.
- Études
- 21
- Depuis 2023
- 12
- Le plus récent
- 2026
- PeauClinique
Healthy Hair, Skin & Nails Blend
Biotin (vitamin B7) is an essential cofactor for five carboxylases, and frank biotin deficiency causes alopecia and dermatitis that resolve with repletion. In people without a deficiency, however, the evidence that supplemental biotin improves hair, skin or nail outcomes is weak: systematic and narrative reviews consistently find only a handful of small, biased or negative studies. High-dose biotin is also a recognised cause of clinically significant interference in streptavidin-biotin immunoassays, producing falsely raised or lowered results for thyroid, cardiac, hormone and other analytes. Other B vitamins have their own dermatological evidence base, with nicotinamide the best studied, showing benefit for keratinocyte-cancer chemoprevention in immunocompetent high-risk patients but no benefit in organ-transplant recipients.
- Études
- 38
- Depuis 2023
- 20
- Le plus récent
- 2026
- PeauPréclinique uniquement
KLOW Blend
KLOW is a marketed combination of four peptides: BPC-157, TB-500 (a fragment-based thymosin beta-4 analogue), GHK-Cu and KPV. A systematic search of PubMed and Europe PMC returned no published study of this four-peptide blend in any model, and no pharmacokinetic, efficacy or safety data exist for the combination. The available literature is component-level: BPC-157 rests almost entirely on rodent work from a small number of laboratories with only two very small uncontrolled human pilot studies; thymosin beta-4 has two randomised phase 2 wound trials; KPV is supported by in vitro and animal anti-inflammatory work; and GHK-Cu is covered separately in this dataset. Only one published study examines any two of the components together.
- Études
- 18
- Depuis 2023
- 11
- Le plus récent
- 2026
- PeauMédicament approuvé
Melanotan 2
Melanotan II and afamelanotide are synthetic analogues of alpha-melanocyte-stimulating hormone that act at melanocortin receptors to increase eumelanin synthesis. Afamelanotide (a selective, largely MC1R-directed analogue) is an approved medicine for erythropoietic protoporphyria supported by randomised placebo-controlled trials and post-authorisation safety cohorts, and has been trialled with narrowband UV-B in vitiligo. Melanotan II is a non-selective, unlicensed peptide sold illegally for tanning; it has never been through a completed efficacy or safety programme; beyond a 1996 pilot study and two small placebo-controlled crossover trials in erectile dysfunction (1998 and 2000), its published human literature consists mainly of adverse-event case reports, including eruptive and dysplastic naevi, melanoma and mucosal melanoma, priapism, renal infarction and systemic reactions.
- Études
- 36
- Depuis 2023
- 13
- Le plus récent
- 2026
Dernières recherches publiées
A framework for the safety evaluation of peptides in cosmetics.
Current Research in Toxicology · revue de l'évaluation historique de la sécurité des peptides cosmétiques plus un cadre bioinformatique proposé en six outils
PubMed · 41953401Copper(II)-Tripeptide Complexes as Potential Skin Healing Agents: Synthesis, Characterization, and Wound Repair Ability.
ChemMedChem · synthèse et caractérisation de complexes cuivre(II)-tripeptide avec tests de réparation de plaies
PubMed · 42047624Overview of Short Peptides for Hair Loss.
Biomedicines · revue narrative de peptides courts étudiés pour la perte de cheveux
PubMed · 42072405A Torilis japonica Extract-GHK-Cu Complex Attenuates Th2 Cytokines and Promotes Keratinocyte Recovery: A Potential Antioxidant Strategy for Atopic Dermatitis.
Antioxidants (Basel) · TNF-alpha/IFN-gamma-stimulated HaCaT keratinocyte model of atopic dermatitis
PubMed · 42510549Augmented Skin Beneficial Effects of Thermus Thermophilus and Bacillus Subtilis Mixed-Culture Ferment Extract by Tripeptide GHK-Cu.
Skin Research and Technology · in vitro (LPS-stimulated macrophages), ex vivo skin, plus human application testing
PubMed · 42573538GHK-Cu as a Bioactive Metallopeptide and Drug-Delivery Cargo: Coordination Chemistry, Formulation Science, Therapeutic Evidence, and a Translational Roadmap.
Pharmaceutics · structured systematic evidence-mapping review of PubMed, Europe PMC, ClinicalTrials.gov and EU/US/ICH regulatory sources to August 2026; no quantitative pooling
PubMed · 42797253Multi-Target Restoration of Dermal Elastic Fibers Through Elastin Upregulation, Elastase Suppression, and Scaffold Reinforcement.
Current Issues in Molecular Biology · human dermal fibroblast cultures; multi-ingredient comparison
PubMed · 42193036Peptide-enriched hydrogel formulation for sensitive and damaged skin: from design to application testing.
Scientific Reports · formulation development plus in vitro human skin cell assays and dermatological testing in human participants
PubMed · 42032121
À des fins de recherche uniquement. Non destiné à la consommation humaine, au diagnostic, au traitement ou à la prévention de toute condition. Rien sur cette page ne constitue un avis médical.